Inhaled nitric oxide

Ended Awarded Last action

Contract number
36C24520F0384
Awardee
Awarding agency
Obligated
$173,555

Award facts

Contract value 51% obligated
  • $173,554.70 Current, with exercised options
  • $341,058.70 Potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Bedminster, NJ 07921, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00011 -$31,360
Funding Only Action P00010 · Nitric oxide DC VAMC -$47,001
Funding Only Action P00009 -$2,424
Exercise an Option P00008 · Option year 4 inhaled nitric oxide $40,102
Supplemental Agreement for work within scope P00007 · Option year 1 inhaled nitric oxide decrease -$88,059
Supplemental Agreement for work within scope P00006 · Additional funding/ increase quantity $5,000
Exercise an Option P00005 · Option year 3 inhaled nitric oxide $80,023
Supplemental Agreement for work within scope P00004 · Deobligate funding inhaled nitric oxide -$41,975
Supplemental Agreement for work within scope P00002 · Inhaled nitric oxide vaccine mandate $0
Exercise an Option P00003 · Inhaled nitric oxide option year 2 $54,538
Exercise an Option P00001 · Inhaled nitric oxide option year 1 $102,355
Original award $102,355
Show all 12

About this award

INO Therapeutics LLC was awarded a delivery order valued at $341,058.70 by Veterans Integrated Service Network (VISN) 5 for the supply of inhaled nitric oxide (INO) therapeutic gas to the Nitric Oxide Division at the Durham VA Medical Center (VAMC). This firm fixed-price contract, awarded on March 16, 2020, with a completion date of March 15, 2025, represents a continuation of the company's primary service offering—specialized medical gas delivery to federal healthcare facilities. The award carries no set-aside designation and is issued under the Pharmaceuticals and Drugs GSA Supply Schedule (FSS-61-IB), with performance centered at the vendor's location in Bedminster, New Jersey.

INO Therapeutics LLC, headquartered in Hazelwood, Missouri, is a specialized supplier of inhaled nitric oxide and respiratory therapy systems with a long-standing relationship with the Department of Veterans Affairs, dating to its SAM.gov registration in February 2002. The company maintains multiple Blanket Purchase Agreements across various VISNs and the Defense Health Agency, collectively valued at several million dollars, which enable the issuance of task orders for medical gas supply and delivery services. Inhaled nitric oxide is a critical therapeutic agent used in the treatment of neonatal, pediatric, and adult critical care patients, making INO Therapeutics' consistent delivery of this specialized medical gas essential to VA healthcare operations.

Quick answers

Who was awarded contract 36C24520F0384?

36C24520F0384 was awarded to INO Therapeutics LLC by Veterans Integrated Service Network 5 (Veterans Health Administration) on March 16, 2020.

How much is contract 36C24520F0384 worth?

The government has obligated $173,555 on 36C24520F0384. Its potential value, with all options, is $341,059.

Is contract 36C24520F0384 an order under another contract?

Yes. 36C24520F0384 is a delivery order under V797D60737, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36C24520F0384 competed?

The extent of competition for 36C24520F0384 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award